STUDY OF EFFECT OF MILTOWN (2-METHYL-2-N-PROPYL-1,3-PROPANEDIOL DICARBAMATE) ON PSYCHIATRIC STATES
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
1954 • 149 citations
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS. A Textbook of Pharmacology, Toxicology and Therapeutics for Physicians and Medical Students
1941 • 125 citations
THE PHARMACOLOGICAL PROPERTIES OF α: β DIHYDROXY‐γ‐(2‐METHYLPHENOXY)‐PROPANE (MYANESIN)
1946 • 83 citations
Some Anticonvulsant Agents Derived from 1,3-Propanediols
1951 • 72 citations
ORAL "MYANESIN" IN TREATMENT OF SPASTIC AND HYPERKINETIC DISORDERS
1948 • 32 citations
SOME EFFECTS OF MYANESIN® IN PSYCHIATRIC PATIENTS
1949 • 29 citations
CLINICAL OBSERVATIONS ON TOLSEROL IN HANDLING ANXIETY TENSION STATES
1950 • 19 citations
Mephenesin in Anxiety-tension States
1952 • 13 citations
ORALLY GIVEN MEPHENESIN IN INFANTILE CEREBRAL PALSY
1950 • 9 citations
Anticonvulsant Activity of 2,2-Disubstituted-l,3-Propanediols in Electroshock Seizures
1951 • 8 citations
Progress in the Clinical Use of 3-(Ortho-Toloxy)-1, 2-Propanediol (Mephenesin) in Neurologic Disorders
1950 • 7 citations